Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet

This study outlines the development of a cost-effective, extended-release febuxostat (FEB) tablet using activated charcoal as an adsorbent to enhance drug release. FEB, a BCS Class II drug, presents formulation challenges due to low solubility and high lipophilicity. We evaluated eight formulations...

全面介紹

書目詳細資料

Principais autores:	Israa Hamid Al-Ani, Mohammad Hailat, Dina J. Mohammed, Sina Mahmoud Matalqah, Alaa Azeez Abu Dayah, Bashar J. M. Majeed, Riad Awad, Lorena Filip, Wael Abu Dayyih
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2024-09-01
叢編:	Molecules
主題:	FEB extended release bioavailability charcoal tablet
在線閱讀:	https://www.mdpi.com/1420-3049/29/19/4629
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!